# A Prospective Trial Of Oral Lead Chelation To Slow Renal Function Decline In Lead-Loaded Type 2 Diabetic Nephropathy Patients

> **NCT07709871** · NA · NOT_YET_RECRUITING · sponsor: **The Fourth Affiliated Hospital of Zhejiang University School of Medicine** · enrollment: 42 (estimated)

## Conditions studied

- Type 2 Diabetic Nephropathy With Elevated Blood Lead Burden

## Interventions

- **DRUG:** Dimercaptosuccinic acid oral chelation therapy

## Key facts

- **NCT ID:** NCT07709871
- **Lead sponsor:** The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07709871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07709871, "A Prospective Trial Of Oral Lead Chelation To Slow Renal Function Decline In Lead-Loaded Type 2 Diabetic Nephropathy Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07709871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*